IPXL
Income statement / Annual
Last year (2017), Impax Laboratories, Inc.'s total revenue was $775.79 M,
a decrease of 5.90% from the previous year.
In 2017, Impax Laboratories, Inc.'s net income was -$469.29 M.
See Impax Laboratories, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
| Period Ended |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
12/31/2010 |
12/31/2009 |
12/31/2008 |
| Operating Revenue |
$775.79 M |
$824.43 M |
$860.47 M |
$596.05 M |
$511.50 M |
$581.69 M |
$512.92 M |
$879.51 M |
$358.41 M |
$210.07 M |
| Cost of Revenue |
$535.12 M
|
$975.53 M
|
$508.07 M
|
$283.40 M
|
$312.20 M
|
$299.14 M
|
$254.62 M
|
$340.25 M
|
$170.31 M
|
$91.97 M
|
| Gross Profit |
$240.66 M
|
-$151.10 M
|
$352.40 M
|
$312.65 M
|
$199.30 M
|
$282.55 M
|
$258.30 M
|
$539.26 M
|
$188.10 M
|
$118.10 M
|
| Gross Profit Ratio |
0.31
|
-0.18
|
0.41
|
0.52
|
0.39
|
0.49
|
0.5
|
0.61
|
0.52
|
0.56
|
| Research and Development Expenses |
$80.85 M
|
$133.43 M
|
$76.98 M
|
$79.11 M
|
$68.85 M
|
$81.32 M
|
$82.70 M
|
$86.22 M
|
$63.27 M
|
$59.81 M
|
| General & Administrative Expenses |
$216.27 M
|
$0.00
|
$0.00
|
$0.00
|
$16.55 M
|
$9.77 M
|
$0.00
|
$0.00
|
$14.70 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$120.29 M
|
$108.47 M
|
$0.00
|
$0.00
|
$39.71 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$216.27 M
|
$201.83 M
|
$201.29 M
|
$139.39 M
|
$136.83 M
|
$118.24 M
|
$68.48 M
|
$53.33 M
|
$54.41 M
|
$47.90 M
|
| Other Expenses |
$249.37 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$546.49 M
|
$335.26 M
|
$278.27 M
|
$218.50 M
|
$205.69 M
|
$199.56 M
|
$151.18 M
|
$139.56 M
|
$117.68 M
|
$107.71 M
|
| Cost And Expenses |
$1.08 B
|
$1.31 B
|
$786.33 M
|
$501.90 M
|
$517.89 M
|
$498.70 M
|
$405.80 M
|
$479.80 M
|
$288.00 M
|
$199.68 M
|
| Interest Income |
$0.00
|
$1.02 M
|
$1.04 M
|
$1.47 M
|
$1.30 M
|
$1.09 M
|
$1.15 M
|
$1.04 M
|
$753.00 K
|
$4.22 M
|
| Interest Expense |
$53.41 M
|
$41.44 M
|
$27.27 M
|
$43.00 K
|
$419.00 K
|
$632.00 K
|
$157.00 K
|
$167.00 K
|
$246.00 K
|
$2.60 M
|
| Depreciation & Amortization |
$135.40 M
|
-$891.18 M
|
$74.25 M
|
$40.83 M
|
$36.01 M
|
$77.93 M
|
$15.68 M
|
$12.65 M
|
$11.27 M
|
$9.90 M
|
| EBITDA |
-$262.15 M |
-$446.54 M |
$143.81 M |
$124.63 M |
$30.92 M |
$161.88 M |
$113.85 M |
$406.70 M |
$82.49 M |
$42.17 M |
| EBITDA Ratio |
-0.34
|
-0.54
|
0.17
|
0.21
|
0.06
|
0.28
|
0.22
|
0.46
|
0.23
|
0.2
|
| Operating Income Ratio |
-0.52
|
0.6
|
0.08
|
0.15
|
-0.01
|
0.14
|
0.19
|
0.45
|
0.2
|
0.02
|
| Total Other Income/Expenses Net |
-$48.27 M
|
-$1.07 B
|
-$10.20 M
|
$1.74 M
|
$152.03 M
|
$319.00 K
|
-$1.60 M
|
$555.00 K
|
$564.00 K
|
$25.75 M
|
| Income Before Tax |
-$450.96 M
|
-$576.33 M
|
$59.37 M
|
$90.56 M
|
$146.94 M
|
$83.31 M
|
$98.01 M
|
$393.88 M
|
$70.98 M
|
$29.67 M
|
| Income Before Tax Ratio |
-0.58
|
-0.7
|
0.07
|
0.15
|
0.29
|
0.14
|
0.19
|
0.45
|
0.2
|
0.14
|
| Income Tax Expense |
$18.33 M
|
-$104.29 M
|
$20.37 M
|
$33.21 M
|
$45.68 M
|
$27.44 M
|
$32.62 M
|
$143.52 M
|
$21.01 M
|
$10.97 M
|
| Net Income |
-$469.29 M
|
-$472.03 M
|
$39.00 M
|
$57.35 M
|
$101.26 M
|
$55.87 M
|
$65.50 M
|
$250.42 M
|
$50.06 M
|
$18.70 M
|
| Net Income Ratio |
-0.6
|
-0.57
|
0.05
|
0.1
|
0.2
|
0.1
|
0.13
|
0.28
|
0.14
|
0.09
|
| EPS |
-6.53 |
-6.63 |
0.56 |
0.84 |
1.51 |
0.85 |
1.02 |
4.04 |
0.83 |
0.32 |
| EPS Diluted |
-6.53 |
-6.63 |
0.54 |
0.81 |
1.47 |
0.82 |
0.97 |
3.82 |
0.82 |
0.31 |
| Weighted Average Shares Out |
$71.86 M
|
$71.15 M
|
$69.64 M
|
$68.19 M
|
$66.92 M
|
$65.66 M
|
$64.13 M
|
$62.04 M
|
$60.28 M
|
$59.07 M
|
| Weighted Average Shares Out Diluted |
$71.86 M
|
$71.15 M
|
$72.03 M
|
$70.53 M
|
$68.66 M
|
$68.40 M
|
$67.32 M
|
$65.57 M
|
$61.08 M
|
$60.78 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
